Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FBYVX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,294
Award facts
- Contract value 100% obligated
- $24,293.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of September 30, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company has consistently secured contracts with the DLA covering an extensive portfolio of pharmaceutical products ranging from specialty medications to over-the-counter items. As an established federal contractor registered in SAM.gov since 2001, the company leverages its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust track record of pharmaceutical product deliveries to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FBYVX?
SPE2DB25FBYVX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FBYVX worth?
The government has obligated $24,294 on SPE2DB25FBYVX.
Is contract SPE2DB25FBYVX an order under another contract?
Yes. SPE2DB25FBYVX is a delivery order under SPE2DB24D9105, an indefinite delivery contract.
Was contract SPE2DB25FBYVX competed?
The extent of competition for SPE2DB25FBYVX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award